| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GDC-0941 | FIMM | pan-cancer | AAC | -0.27 | 0.1 |
| mRNA | BRD9876:MK-1775 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.25 | 0.03 |
| mRNA | VX-680 | CTRPv2 | pan-cancer | AAC | -0.24 | 0.03 |
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.23 | 0.5 |
| mRNA | lapatinib | FIMM | pan-cancer | AAC | -0.22 | 0.2 |
| mRNA | BRD-K01737880 | CTRPv2 | pan-cancer | AAC | -0.2 | 0.1 |
| mRNA | Docetaxel | CTRPv2 | pan-cancer | AAC | -0.19 | 0.0009 |
| mRNA | Sunitinib | FIMM | pan-cancer | AAC | -0.19 | 0.3 |
| mRNA | FQI-1 | CTRPv2 | pan-cancer | AAC | -0.18 | 0.001 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.17 | 0.02 |